Vivos Therapeutics Inc [NASDAQ: VVOS] jumped around 148296.84 points on Tuesday, while shares priced at $148300.0 at the close of the session, up 22.47%.
Vivos Therapeutics Inc stock is now 61.92% up from its year-to-date (YTD) trading value. VVOS Stock saw the intraday high of $4.68 and lowest of $3.55 per share. The company’s 52-week high price is 6.28, which means current price is +95.45% above from all time high which was touched on 01/17/25.
Compared to the average trading volume of 148.30K shares, VVOS reached a trading volume of 28129580 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Vivos Therapeutics Inc [VVOS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VVOS shares is $4.22 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VVOS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 5.17, with the Price to Cash per share for the same quarter was set at 0.40.
How has VVOS stock performed recently?
Vivos Therapeutics Inc [VVOS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.30. With this latest performance, VVOS shares gained by 59.92% in over the last four-week period, additionally sinking by -18.70% over the last 6 months – not to mention a drop of -9.79% in the past year of trading.
Vivos Therapeutics Inc [VVOS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Vivos Therapeutics Inc [VVOS] shares currently have an operating margin of -77.28% and a Gross Margin at 54.55%. Vivos Therapeutics Inc’s Net Margin is presently recorded at -76.82%.
Return on Equity for this stock declined to -97.35%, with Return on Assets sitting at -97.35%.
Insider trade positions for Vivos Therapeutics Inc [VVOS]
There are presently around $9.25%, or 12.24%% of VVOS stock, in the hands of institutional investors. The top three institutional holders of VVOS stocks are: STRATEGIC WEALTH INVESTMENT GROUP, LLC with ownership of 0.13 million shares, which is approximately 3.9893%. GEODE CAPITAL MANAGEMENT, LLC, holding 20691.0 shares of the stock with an approximate value of $$45933.0 in VVOS stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$36000.0 in VVOS stock with ownership which is approximately 0.4956%.
